Nanobiotix
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
60 disclosures on record
Evolution of the disclosed total
0%0.5%1%1.5%
Oct 2025Jan 2026Apr 2026Jul 2026
January 23, 2018 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| March 8, 2019 | Voleon Capital Management LP | 0.70% | July 22, 2019 |
| February 28, 2019 | Voleon Capital Management LP | 0.62% | July 22, 2019 |
| February 22, 2019 | Voleon Capital Management LP | 0.51% | July 22, 2019 |
| September 18, 2018 | Voleon Capital Management LP | 0.41% | September 20, 2018 |
| September 7, 2018 | Voleon Capital Management LP | 0.52% | September 20, 2018 |
| August 7, 2018 | Marshall Wace LLP | 0.49% | August 9, 2018 |
| August 2, 2018 | Marshall Wace LLP | 0.55% | August 9, 2018 |
| July 27, 2018 | Marshall Wace LLP | 0.61% | August 9, 2018 |
| February 28, 2018 | GSA Capital Partners LLP | 0.48% | March 2, 2018 |
| January 23, 2018 | GSA Capital Partners LLP | 0.50% | March 2, 2018 |
Other companies sold short in France
- Ubisoft Entertainment 13.90% of the capital sold short
- Valeo 10.92% of the capital sold short
- Teleperformance 8.94% of the capital sold short
- Renault 6.44% of the capital sold short
- FDJ United 6.17% of the capital sold short
- Remy Cointreau 5.36% of the capital sold short
- Viridien 5.25% of the capital sold short
- Alstom 5.23% of the capital sold short
- Abivax 5.04% of the capital sold short
- Worldline 4.48% of the capital sold short
- Vusiongroup 4.08% of the capital sold short
- Forvia 4.06% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Nanobiotix, source AMF, data as at August 7, 2026, https://www.quivad.com/action/nanobiotix?page=2